Target intelligence / Profile preview

EF-hand containing protein

Molecular classification
Other (structural motif family), Calcium-binding protein
01

Overview

EF-hand containing proteins are a large and structurally diverse superfamily defined by the presence of the EF-hand motif, a helix–loop–helix structural domain that binds calcium ions with high selectivity, mediating processes ranging from calcium signaling to buffering[1][2][3][5][6]. Members include calmodulin, troponin C, parvalbumin, S100 family, and many others, with functions spanning from regulatory (signal transduction via conformational change upon Ca2+ binding) to structural (buffering intracellular calcium without major conformational change)[2][5][6]. This is not a single protein or "target" in the sense used for drug discovery, but rather a defining motif within many functionally specialized proteins; thus, listing the family alone ("EF-hand containing proteins") is too broad to match specific therapeutic targeting or indication[1][5]. As a family, there are no broadly interacting compounds; some individual members such as calmodulin have interacting compounds (e.g., trifluoperazine), but the entire group is not broadly targetable. "EF-hand containing proteins" is an imprecise entry if used as a druggable target; it refers to a protein superfamily, not an individual molecular entity. For drug discovery or biomarker use, a specific protein such as "Calmodulin" or "S100B" should be used[1][5][6].

Other names
EF-hand proteinEF-hand calcium-binding protein
02

Mechanism of action

Calcium binding induces conformational changes, modulating interaction with various target proteins[2][6]

03

Biological functions

Calcium signal transductionCalcium bufferingModulation of enzymatic activityRegulation of cytoskeletal dynamicsControl of cell proliferation, cell cycle, and apoptosisCell–cell adhesion
04

Disease associations

Cancer (e.g., S100B, calmodulin)Neurodegenerative diseaseCardiovascular diseaseMuscle disordersOther
05

Safety considerations

Targeting the family broadly would affect calcium signaling in many tissues; specificity and off-target effects are major concerns
06

Biomarkers

S100B (melanoma, glioma)[5]Calbindin D28K (neurological disease marker)[5]

Beyond the preview

Go deeper on EF-hand containing protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EF-hand containing protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call